#Israel #AI Development #Ultrasound Technology #Ramat Gan #Pulsenmore

Pulsenmore Selected for Pathbreaking AI Development Project

Pulsenmore Ltd. (NASDAQ: PLSM) (TASE: PLSM), a leader in the field of connected home ultrasound technology, has recently announced its selection for a significant healthcare AI initiative supported by the Israel Innovation Authority (IIA) and the Ministry of Health. This project, which has received funding of $1 million, is intended to propel the development of innovative AI applications that enhance the efficiency of clinical workflows and broaden the scalability of its home ultrasound platform.

The initiative aims to fast-track the integration of groundbreaking AI technologies in healthcare by creating a unique regulatory sandbox. This regulatory framework allows Pulsenmore to work directly with regulators and the healthcare sector, facilitating the development, evaluation, and clinical validation of its solutions. This structured approach offers a clear pathway for incorporating advanced technologies into healthcare systems, both in Israel and globally.

Revolutionizing Prenatal Care

Pulsenmore’s home ultrasound platform is designed specifically for pregnant women, enabling them to carry out physician-prescribed ultrasound scans from the comfort of their homes. By connecting the ultrasound device to a personal smartphone, women can securely transmit the results to healthcare professionals, facilitating timely clinical decisions. Notably, the technology is already utilized by several prominent healthcare organizations, such as Clalit Health Services, Israel's largest Health Maintenance Organization (HMO), as well as various clinical partners around the world.

To date, over 250,000 home ultrasound scans have been completed using the Pulsenmore platform, establishing the largest real-world datasets of prenatal ultrasound examinations globally. This extensive dataset serves as a robust foundation for developing and clinically validating AI tools.

In its current iteration, each ultrasound examination is comprehensively reviewed by a physician before any results are communicated back to the patient. The AI applications being developed through this project aim to automate the identification of critical ultrasound parameters, allowing physicians to focus on the most pertinent information and reducing the time required for reviews. This innovation is expected not only to expedite patient outcomes but also to alleviate the burden on clinicians, particularly as the global healthcare workforce faces an increasing shortage of skilled professionals.

Collaborative Development

An integral part of this initiative involves collaboration with Beilinson Hospital, which is part of the Clalit Health Services network. This partnership will focus on both the technical development and clinical validation of Pulsenmore’s AI applications, ensuring that they meet the rigorous standards required in medical practice.

Dr. Elazar Sonnenschein, Founder and CEO of Pulsenmore, stated, “This program signifies more than just artificial intelligence; it marks a transformative step in the evolution of our platform. Our goal is to furnish healthcare providers with tools that enhance their operational efficiency, allowing them to focus on what truly matters – delivering high-quality care to a greater number of patients.” He also expressed confidence that the combination of their unique dataset, the collaboration with leading healthcare organizations, and the supportive regulatory framework of this program will pave the way for the integration of AI-driven software solutions that will continue to enrich the capabilities of their platform.

Moving Forward

As Pulsenmore advances through this project, it remains committed to revolutionizing maternal health through accessible home ultrasound technology. By improving imaging quality and integrating telemedicine, Pulsenmore is redefining prenatal care, making it more patient-centric and improving comprehensive care continuity. For further insights on Pulsenmore and its innovative solutions, visit www.pulsenmore.com.

This project exemplifies the potential benefits of AI in healthcare, particularly in prenatal care, where timely and accurate assessments can significantly impact maternal and fetal health outcomes. The successful implementation of these technologies will likely set a precedent for future advancements in healthcare AI applications.